SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-000370
Filing Date
2022-01-04
Accepted
2022-01-04 06:30:20
Documents
16
Period of Report
2022-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea153305-8k_enzobio.htm   iXBRL 8-K 37270
2 COOPERATION AGREEMENT, DATED JANUARY 3, 2022 BY AND AMONG ENZO BIOCHEM, INC., BR ea153305ex10-1_enzobio.htm EX-10.1 71062
3 PRESS RELEASE DATED JANUARY 3, 2022 ea153305ex99-1_enzobio.htm EX-99.1 13423
7 GRAPHIC ex99-1_001.jpg GRAPHIC 2545
8 GRAPHIC ex99-1_002.jpg GRAPHIC 2677
  Complete submission text file 0001213900-22-000370.txt   325240

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE enz-20220103_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE enz-20220103_pre.xml EX-101.PRE 22350
6 XBRL SCHEMA FILE enz-20220103.xsd EX-101.SCH 2726
10 EXTRACTED XBRL INSTANCE DOCUMENT ea153305-8k_enzobio_htm.xml XML 3465
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 22504024
SIC: 8071 Services-Medical Laboratories